L-histidine decarboxylase and Tourette's syndrome

New England Journal of Medicine

Volumn 362, Issue 20, 2010, Pages 1901-1908

  Ercan Sencicek, A Gulhan ^a   Stillman, Althea A ^a   Ghosh, Ananda K ^b   Bilguvar, Kaya ^a   O'Roak, Brian J ^c   Mason, Christopher E ^b   Abbott, Thomas ^a   Gupta, Abha ^a   King, Robert A ^a   Pauls, David L ^d   Tischfield, Jay A ^e,f   Heiman, Gary A ^e,f   Singer, Harvey S ^g   Gilbert, Donald L ^h   Hoekstra, Pieter J ⁱ   Morgan, Thomas M ^j   Loring, Erin ^a   Yasuno, Katsuhito ^a   Fernandez, Thomas ^a   Sanders, Stephan ^a   Louvi, Angeliki ^a   Cho, Judy H ^a   Mane, Shrikant ^a   Colangelo, Christopher M ^a   Biederer, Thomas ^a   Lifton, Richard P ^a   Gunel, Murat ^a   State, Matthew W ^a   more..

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d HARVARD UNIVERSITY   (United States)

^e New Jersey Center for Tourette Syndrome and Associated Disorders   (United States)

^f RUTGERS UNIVERSITY   (United States)

^g JOHNS HOPKINS UNIVERSITY   (United States)

^h UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

ⁱ UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^j VANDERBILT UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE; HISTIDINE DECARBOXYLASE;

ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; GENE MUTATION; GILLES DE LA TOURETTE SYNDROME; HUMAN; LINKAGE ANALYSIS; NEUROTRANSMISSION; PEDIGREE; PRIORITY JOURNAL; TIC;

EID: 77952629167     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa0907006     Document Type: Article

References (20)

1. Jeffries KJ, Schooler C, Schoenbach C, Herscovitch P, Chase TN, Braun AR. The functional neuroanatomy of Tourette's syndrome: an FDG PET study III: functional coupling of regional cerebral metabolic rates. Neuropsychopharmacology 2002;27:92-104. (Pubitemid 34626746)
2. Leckman JF, Bloch MH, Scahill L, King RA. Tourette syndrome: the self under siege. J Child Neurol 2006;21:642-649
3. Price RA, Kidd KK, Cohen DJ, Pauls DL, Leckman JF. A twin study of Tourette syndrome. Arch Gen Psychiatry 1985;42: 815-820
4. Abelson JF, Kwan KY, O'Roak BJ, et al. Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 2005;310:317-320
5. Katayama KYK, Yamada K, Ornthanalai VG, et al. Slitrk1-deficient mice display elevated anxiety-like behavior and noradrenergic abnormalities. Mol Psychiatry 2008;15:177-184
6. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell 2001;104:545-556
7. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559-575 (Pubitemid 47330214)
8. Iafrate AJ, Feuk L, Rivera MN, et al. Detection of large-scale variation in the human genome. Nat Genet 2004;36:949-951 (Pubitemid 39167488)
9. Fleming JV, Wang TC. The production of 53-55-kDa isoforms is not required for rat L-histidine decarboxylase activity. J Biol Chem 2003;278:686-694
10. Ohtsu H, Tanaka S, Terui T, et al. Mice lacking histidine decarboxylase exhibit abnormal mast cells. FEBS Lett 2001;502:53-56 (Pubitemid 32722059)
11. Tsirka S, Coffino P. Dominant negative mutants of ornithine decarboxylase. J Biol Chem 1992;267:23057-23062
12. Haas HL, Sergeeva OA, Selbach O. Histamine in the nervous system. Physiol Rev 2008;88:1183-1241
13. Ohtsu H, Watanabe T. New functions of histamine found in histidine decarboxylase gene knockout mice. Biochem Biophys Res Commun 2003;305:443-447 (Pubitemid 36579249)
14. Kubota Y, Ito C, Sakurai E, Sakurai E, Watanabe T, Ohtsu H. Increased methamphetamine-induced locomotor activity and behavioral sensitization in histamine-deficient mice. J Neurochem 2002;83:837-845 (Pubitemid 35316033)
15. Dere E, De Souza-Silva MA, Spieler RE, et al. Changes in motoric, exploratory and emotional behaviours and neuronal acetylcholine content and 5-HT turnover in histidine decarboxylase-KO mice. Eur J Neurosci 2004;20:1051-1058 (Pubitemid 39141311)
16. Saka E, Graybiel AM. Pathophysiology of Tourette's syndrome: striatal pathways revisited. Brain Dev 2003;25:Suppl 1:S15-S19.
17. Acevedo SF, Pfankuch T, Ohtsu H, Raber J. Anxiety and cognition in female histidine decarboxylase knockout (Hdc(-/-)) mice. Behav Brain Res 2006;168:92-99 (Pubitemid 43153771)
18. Fox GB, Esbenshade TA, Pan JB, et al. Selective H3 receptor (H3R) blockade: broad efficacy in cognition and schizophrenia. Inflamm Res 2005;54:Suppl 1: S23-S2
19. Fox GB, Esbenshade TA, Pan JB, et al. Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-methylpyrrolidinyl]ethyl}- benzofuran-5-yl) benzonitrile]. II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist. J Pharmacol Exp Ther 2005;313:176-190
20. Ligneau X, Landais L, Perrin D, et al. Brain histamine and schizophrenia: potential therapeutic applications of H3-receptor inverse agonists studied with BF2.649. Biochem Pharmacol 2007;73: 1215-1224 (Pubitemid 46420689)